Premium
Comparative analysis of the cost and effectiveness of generic and brand‐name antibiotics: the case of uncomplicated urinary tract infection
Author(s) -
Lin YuShiuan,
Jan IShiow,
Cheng ShouHsia
Publication year - 2017
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.4122
Subject(s) - medicine , generic drug , antibiotics , brand names , cohort , urinary system , propensity score matching , health care , cohort study , drug , pediatrics , advertising , pharmacology , economics , microbiology and biotechnology , business , biology , economic growth
Purpose Generic medications used for chronic diseases are beneficial in containing healthcare costs and improving drug accessibility. However, the effects of generic drugs in acute and severe illness remain controversial. This study aims to investigate treatment costs and outcomes of generic antibiotics prescribed for adults with a urinary tract infection in outpatient settings. Methods The data source was the Longitudinal Health Insurance Database of Taiwan. We included outpatients aged 20 years and above with a urinary tract infection who required one oral antibiotic for which brand‐name and generic products were simultaneously available. Drug cost and overall healthcare expense of the index consultation, healthcare cost during a 42‐day follow‐up period, and treatment failure rates were the main dependent variables. Data were compared between brand‐name and generic users from the entire cohort and a propensity score‐matched samples. Results Results from the entire cohort and propensity score‐matched samples were similar. Daily antibiotic cost was significantly lower among generic users than brand‐name users. Significant lower total drug claims of the index consultation only existed in patients receiving the investigated antibiotics, while the drug price between brand‐name and generic versions were relatively large (e.g., >50%). The overall healthcare cost of the index consultation, healthcare expenditure during a 42‐day follow‐up period, and treatment failure rates were similar between the two groups. Conclusions Compared with those treated with brand‐name antibiotics, outpatients who received generic antibiotics had equivalent treatment outcomes with lower drug costs. Generic antibiotics are effective and worthy of adoption among outpatients with simple infections indicating oral antibiotic treatment. Copyright © 2016 John Wiley & Sons, Ltd.